Don’t Forget to take This Vaccine

On July 19th a small pharmaceutical company based in Austria, Affiris, announced the beginning of clinical trials for a new drug intended to halt the onset of Alzheimer’s disease in humans. The drug, currently known as Affitope AD01, will be administered to 24 patients diagnosed with mild to moderate symptoms of the disease. [...]